Xenon Pharmaceuticals Inc. (XENE) declined -5.37% or -0.28 to $4.85. It is close to 89069 shares traded, which is 96.84% compare to the average total volume 91972. The market cap of XENE is $68.73 million. The year to date change is 78.26%. The 52 week price range is from $2.1 to $5.8. Price of XENE have changed -5.96% during last week. It have changed 7.89% over last month, 73.73% over last 3 months, 65.32% over last 6 months and 38.51% over one year.
Some investors will use 50-day and 200-day Moving Averages as support and resistance levels. Those moving average will be very helpful most of time. The 50-day Moving Averages for XENE is 4.47. It is -7.84% below current price. The 200-day Moving Averages for XENE is 3.31. It is -31.75% below current price. The 52-week High is 5.8. It is 19.59% from the current price. The 52-week Low is 2.1. It is -56.70% from current price.
Some people may be interesting about short interest ratio of a stock. The short interest ratio of XENE is 1.58 on 2018-03-29. Short % to float is 1.11%. There are some statistics of XENE. It is has market cap $68.73 million. The share outstanding is 14.17 million. The average volume is 91972. The revenue is 295000. The percent of top 15 Institution holding is 82.50%. Return on equity is how much of net income returned as a percentage of the total amount of shareholder equity found on the balance sheet. Return on equity (ROE) of XENE is -56.43%. Return on assets (ROA) is an indicator that shows how profitable a company is using its total assets to generate earnings. Return on Assets (ROA) of XENE is -49.88%.